– Reuters
Arcutis Biotherapeutics Q2 EPS $(0.84) Up From $(0.94) YoY
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(0.84) per share. This is a 10.64 percent increase over losses of $(0.94) per share from the same period last year.